UK markets closed

Nanobiotix S.A. (NNBXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
9.100.00 (0.00%)
At close: 02:47PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.86
52-week change 3117.19%
S&P500 52-week change 3-15.73%
52-week high 319.85
52-week low 37.32
50-day moving average 318.39
200-day moving average 311.82

Share statistics

Avg vol (3-month) 364
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 827.71M
% held by insiders 13.78%
% held by institutions 126.25%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,795.86%

Management effectiveness

Return on assets (ttm)-29.16%
Return on equity (ttm)-198.69%

Income statement

Revenue (ttm)2.66M
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)0.80%
Gross profit (ttm)2.65M
EBITDA -47.6M
Net income avi to common (ttm)-43M
Diluted EPS (ttm)-1.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)63.02M
Total cash per share (mrq)1.81
Total debt (mrq)45.11M
Total debt/equity (mrq)2,517.08
Current ratio (mrq)1.71
Book value per share (mrq)0.05

Cash flow statement

Operating cash flow (ttm)-32.32M
Levered free cash flow (ttm)-19.73M